Dr. David Jackman of Dana-Farber Cancer Institute discusses how after introduction of a clinical pathway in metastatic NSCLC, cost of care decreased significantly with no compromise in survival.

By Dr. Muhammad Beg 

Dr. Muhammad Beg discusses the challenges and next steps needed for physical activity monitors to provide relevant information that can change the current state of oncology practice.

Related Article: Promise of Wearable Physical Activity Monitors in Oncology Practice

Dr. Ray Osarogiagbon discusses the need for the development of “real” care teams for lung cancer patients, to foster coordination among the multiple specialists and staff engaged in routine care delivery.

Dr. Robert Miller provides an update on CancerLinQ (Cancer Learning Intelligence Network for Quality), ASCO’s big-data, health information technology platform for oncology practices nationwide.

Dr. Pennell talks to co-author Dr. Maria Silveira about why it can be so difficult for oncologists to refuse chemotherapy treatment to patients near death.

This podcast is introducing JOP's new social media editor, Dr. Deanna Attai.

Dr. Horvitz and his co-authors found that signals about patterns of queries in search logs can predict the future appearance of queries that are highly suggestive of a diagnosis of pancreatic adenocarcinoma.

Author Marge Good discusses the results from this project which demonstrate that trial-specific acuity measurement is a better measure of workload than simply counting the number of patients. The ASCO Clinical Trial Workload Assessment Tool was shown to be feasible and useable in diverse community-based research settings.

The author discusses survivorship care, one of the most

Journal of Oncology Practice Associate Editor Apar Ganti talks with Consultant Editor Nathan Pennell about what readers can expect to see in the pages of JOP starting in 2016.